Myconic Capital Corp. MEDI is poised to acquire a Victoria, British Columbia-based physical therapy clinic exclusively for the Canadian military, Royal Canadian Mounted Police (RCMP), and first responder patients.
Transaction Details: The Vancouver-based investment company, which previously operated as Auralite Investments Inc., inked a letter of intent to purchase Integrated Rehab and Performance Ltd., which operates the clinic, for $1 million.
The sum will be payable in the company’s common shares upon the closing of the transaction, including 5% which would be tradable on the closing date, with the remaining 95% payable quarterly, over the 18 months.
Under the deal, IRP will expand its British Columbia footprint and launch ketamine treatments as part of its offering.
Myconic purchased Mindscape Ketamine & Infusions Therapy PLLC last month for $175,000.
What’s Next: “As Canada continues to be a leader in alternative medicines and treatments, our goal is to aggressively pursue Section 56 exemptions for veteran patients of IRP, to be able to offer access to psychedelic-assisted therapy as an addition to their current treatment plans,” the company’s CEO Robert Meister said Friday.
In addition, IRP will receive a series of bonuses, payable in Myconic’s common shares, once it reaches particular milestones, including:
- Opening two new IRP clinics with at least one registered patient at each, to receive some 200 000 Myconic’s common shares
- Achieving or exceeding CA$2 million ($1.6 million) in total gross revenue in 2022 fiscal year for an additional 250 000 of Myconic’s common shares
- Conducting active studies of wearable physical therapy technology at more than two clinics with a minimum of 20 Canadian Armed Forces veterans as participants to obtain 100 000 commons shares of Myconic
- Supporting one clinical or academic study focusing on the benefits of psychedelic intervention treatments for 100 000 of the company’s shares
- Forwarding 50 patients to internal psychedelic clinics to receive 50 000 common shares of the company
Photo by Hans Reniers on Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.